Neoadjuvant chemoradiation for adenocarcinoma of the pancreas.

@article{Miller1998NeoadjuvantCF,
  title={Neoadjuvant chemoradiation for adenocarcinoma of the pancreas.},
  author={Alexander R. Miller and Emily K. Robinson and Jeffrey E. Lee and Peter W. T. Pisters and Paul J. Chiao and Renato Lenzi and James L Abbruzzese and Douglas B. Evans},
  journal={Frontiers in bioscience : a journal and virtual library},
  year={1998},
  volume={3},
  pages={E193-203}
}
Pancreaticoduodenectomy is performed on carefully selected patients as part of a protocol-based clinical research program emphasizing the importance of multimodality management for patients with potentially resectable adenocarcinoma of the pancreatic head. Treatment schemas emphasize the importance of minimizing toxicity and treatment duration, while attempting to improve therapeutic efficacy. Cytotoxicity is enhanced by combining radiation therapy with more potent radiation-sensitizing agents… CONTINUE READING